Back to Resource Center

Acceptability of a Long-Acting, Multipurpose Vaginal Ring: Findings from a Phase I Trial in the U.S. and Dominican Republic

Women worldwide face risks from pregnancy, HIV, and other sexually transmitted infections (STIs). To date, highly effective contraceptive methods provide no HIV/STI protection, and HIV prevention products, excluding condoms, provide no pregnancy protection. Intravaginal rings (IVRs) delivering antiretrovirals and contraceptives are a promising multipurpose prevention technology (MPT).

Findings provide strong evidence of demand for an MPT IVR that protects from pregnancy and HIV/STIs, lasts longer than 1 month, minimally disrupts menstrual bleeding, and is in women’s control. numberClinicalTrials.gov: #NCT03279120.

September 2022

Click for full info +

Full Info:


Resource Type:

Database
Journal Article
Journal Article
MPT Articles
MPT Article
Resource

Citation:

Women worldwide face risks from pregnancy, HIV, and other sexually transmitted infections (STIs). To date, highly effective contraceptive methods provide no HIV/STI protection, and HIV prevention products, excluding condoms, provide no pregnancy protection. Intravaginal rings (IVRs) delivering antiretrovirals and contraceptives are a promising multipurpose prevention technology (MPT).

Findings provide strong evidence of demand for an MPT IVR that protects from pregnancy and HIV/STIs, lasts longer than 1 month, minimally disrupts menstrual bleeding, and is in women’s control. numberClinicalTrials.gov: #NCT03279120.

View Journal Article

Authors: Tolley, E.E., Zissette, S., Taylor, J., Hanif, H., Ju, S., Schwarz, J., Thurman, A., Tyner, D., Brache, V. and Doncel, G.F.

Health Risks(s):

  • HIV
  • STI / STD
  • Unintended Pregnancy

Product type(s):

  • Contraceptives
  • HIVinhibitor
  • IVR
  • MPTs

Topic(s):

  • MPTs
  • Development
  • Social

Region(s)

  • LAC
  • United States

Back to Resource Center